About us
Our portfolio
Abingworth
Abingworth Stage
Early stage: Seed, Development stage, Clinical co-development
Abingworth Sectors
Life Sciences
Abingworth Investment range
$15m - $30m*
*Total investment per company
accuRx
accuRx Stage
Venture Growth
accuRx Sectors
Technology
Active Partners
Active Partners Stage
Growth, minority or majority investments
Active Partners Sectors
Consumer, Consumer-tech
Active Partners Investment range
£3 - 15m
Advent Life Sciences
Advent Life Sciences Stage
Seed, Series A and beyond
Advent Life Sciences Sectors
Life Sciences: Therapeutics and Medtech
Alpina Partners
Alpina Partners Stage
Growth
Alpina Partners Sectors
Industrials, Software IT, Tech enabled businsess services
Amadeus Capital
Amadeus Capital Stage
Seed, Series A, Growth
Amadeus Capital Sectors
Agritech, Artificial Intelligence, Cyber Security, Fintech, Industry 4.0, Medtech, Urban Stack, Quantum Computing
Amadeus Capital Investment range
£500,000 - £5m
Atlantic Bridge
Atlantic Bridge Stage
Growth stage, Series B and beyond
Atlantic Bridge Sectors
Artificial Intelligence, Augmented Reality, Cloud Infrastructure, Digital Health, Industry 4.0, Network Security
Atlantic Bridge Investment range
€5m - €15m
Atomico
Atomico Stage
Series A and beyond
Atomico Sectors
Sector agnostic
Balderton Capital
Balderton Capital Stage
Series A and beyond
Balderton Capital Sectors
Creative Entertainment, Efficient mobility, Enterprise Software, Data-Driven Health, Fintech, Future of Food, Retail, Security
Cambridge Innovation Capital
Cambridge Innovation Capital Stage
Series A
Cambridge Innovation Capital Sectors
Deep tech, Life Sciences
CloudNC
CloudNC Stage
Venture Growth
CloudNC Sectors
Technology
Connect Ventures
Connect Ventures Stage
Seed
Connect Ventures Sectors
B2B and Consumer Software
Connect Ventures Investment range
£750k - £2m
Crane Capital
Crane Capital Stage
Early stage
Crane Capital Sectors
Deeptech, Entreprise Software
Crane Capital Investment range
£1m to £3m
CyberSmart
CyberSmart Stage
Venture Growth
Dawn
Dawn Stage
Series A and B
Dawn Sectors
B2B software: Data & Analytics, Fintech, Future of Work, Privacy & Security
Dawn Investment range
$3m - $25m
Dementia Discovery Fund
Dementia Discovery Fund Stage
Early stage focus, flexibiltiy to invest at Later stage
Dementia Discovery Fund Sectors
Therapeutics for all forms of dementias
Epsilogen
Epsilogen Stage
Venture Growth
Epsilogen Sectors
Life Sciences
ETF Partners
ETF Partners Stage
Venture Growth: Series A and B
ETF Partners Sectors
Digital Sustainability: Energy Transition, Green Networks, Future Consumer, Mobility, Sustainable Food
ETF Partners Investment range
£2-10m*
*Total investment per company
Eurazeo
Eurazeo Stage
Growth
Eurazeo Sectors
B2B SaaS, Digital Health, Cybersecurity, Infrastructure Software, Fintech
Eurazeo Investment range
€25m+
Evolution Equity Partners
Evolution Equity Partners Stage
Early Growth and Growth
Evolution Equity Partners Sectors
Artificial Intelligence/Machine Learning, Cybersecurity, Enterprise Software
Evolution Equity Partners Investment range
$1m - $30m
FPE Capital
FPE Capital Stage
Growth stage, businesses at breakeven or beyond
FPE Capital Sectors
Software and Services
FPE Capital Investment range
£5 - 20m
Frog Capital
Frog Capital Stage
Series B, Series C and beyond
Frog Capital Sectors
Software including: Artifical Intelligence & Data Applications, Cloud Technology, Digital Health & Wellbeing, Enterprise SaaS, Hrtech, Fintech, Regtech
Frog Capital Investment range
£5-15m
Garrison
Garrison Stage
Venture Growth
Grey Wolf Therapeutics
Grey Wolf Therapeutics Stage
Growth
Grey Wolf Therapeutics Sectors
Life Sciences
Hoxton Ventures
Hoxton Ventures Stage
Early stage
Hoxton Ventures Sectors
Agonostic providing there is a tech component
Hoxton Ventures Investment range
$250m to $5m
Iceotope
Iceotope Stage
Venture Growth
Iceotope Sectors
Technology
IQ Capital
IQ Capital Stage
Seed and Series A
IQ Capital Sectors
Deeptech including: Artificial Intelligence & Machine learning, Cyber Security, Data Analytics, Fintech, Internet of Things, Performance engineering
IQ Capital Investment range
£300k to £5m
Kennett
Kennett Stage
Growth
Kennett Sectors
B2B Software
Kennett Investment range
£7 - £25m
kester
kester Stage
Growth
kester Sectors
Business & Financial Services, Healthcare, Specialist Consumer, TMT
Kindred
Kindred Stage
Seed
Kindred Sectors
Technology driven companies
Kindred Investment range
£500k - £1.5m
Microbiotica
Microbiotica Stage
Growth
Microbiotica Sectors
Life Sciences
Molten Ventures Plc
Molten Ventures Plc Stage
Series A and beyond
Molten Ventures Plc Sectors
Consumer technology, Digital Health & Wellness, Hardware & Deeptech, SaaS and Enterprise
Molten Ventures Plc Investment range
£5m - £50m
MVM Partners
MVM Partners Stage
Growth
MVM Partners Sectors
Healthcare including: Diagnostics, HIT and tech enabled services, Medical Devices, Pharma
Nauta Capital
Nauta Capital Stage
Late Seed and Series A
Nauta Capital Sectors
B2B SaaS, Deeptech applied to large enterprises, Vertically focused enterprise technology
Nauta Capital Investment range
€1 - €5m
Northern Gritstone
Northern Gritstone Stage
Venture
Northern Gritstone Sectors
Clean Tech, Software, Digital & Artificial Intelligence, Electronics, Materials, Manufacturing/Engineering, Life Sciences and Biosciences
Notion Capital
Notion Capital Stage
Early
Notion Capital Sectors
Entreprise technology, SaaS
Notion Capital Investment range
£2 - £10m
Nucleome Therapeutics
Nucleome Therapeutics Stage
Venture
Nucleome Therapeutics Sectors
Life Sciences
OMass Therapeutics
OMass Therapeutics Stage
Venture Growth
OMass Therapeutics Sectors
Life Sciences
Oxford Quantum Circuits
Oxford Quantum Circuits Stage
Venture
Oxford Quantum Circuits Sectors
Technology
OXX
OXX Stage
Scale-up
OXX Sectors
B2B SaaS
OXX Investment range
$5 - 25m
Panoramic
Panoramic Stage
Growth
Panoramic Sectors
Agnostic with a focus on busienesses generating £1m+ of revenues
Panoramic Investment range
£1m - £5m
Paragraf
Paragraf Stage
Venture Growth
Paragraf Sectors
Technology
Partech
Partech Stage
Growth
Partech Sectors
Digital Technology
Partech Investment range
€20m - €70m
Passion Capital
Passion Capital Stage
Pre-seed and seed
Passion Capital Sectors
B2B and B2C Digital Technology
Passion Capital Investment range
£200, 000 - £500, 000
Perspectum
Perspectum Stage
Venture Growth
Perspectum Sectors
Life sciences
PragmatIC
PragmatIC Stage
Venture growth
PragmatIC Sectors
Technology
Prime ventures
Prime ventures Stage
Growth
Prime ventures Sectors
B2B Software, Consumer, High-Tech
Prime ventures Investment range
€15 - 25m
Proximie
Proximie Stage
Venture growth
Proximie Sectors
Life sciences
Quantexa
Quantexa Stage
Venture Growth
Quantexa Sectors
Technology
Quantum Motion
Quantum Motion Stage
Venture Growth
Quantum Motion Sectors
Technology
Quell
Quell Stage
Venture Growth
Quell Sectors
Life Sciences
Scottish Equity Partners
Scottish Equity Partners Stage
Growth stage
Scottish Equity Partners Sectors
Software, Consumer Internet, Tech-enabled services
Scottish Equity Partners Investment range
£10m - £25m
Seedcamp
Seedcamp Stage
Pre-seed and seed
Seedcamp Sectors
Agnostic
Seedcamp Investment range
£200, 000 (pre-seed), up to £500, 000 at seed
SV health investors
SV health investors Stage
Early, with a focus on company creation*
SV health investors Sectors
Biotech**
*SV Health Incestors follow their companies and invest through their life cycles including through to clinical stage and IPO
**SV7 Impact Medicine Fund
Tenpoint Therapeutics
Tenpoint Therapeutics Stage
Venture
Thought Machine
Thought Machine Stage
Venture Growth
Thought Machine Sectors
Technology
UCL technology fund
UCL technology fund Stage
Early
UCL technology fund Sectors
Life sciences, physical sciences, engineering
UCL technology fund Investment range
£100,000 - £6m
Ultraleap
Ultraleap Stage
Venture Growth
Ultraleap Sectors
Technology
Westbridge
Westbridge Stage
Small cap private equity, buy and builds
Westbridge Sectors
B2B and technology enabled companies
Westbridge Investment range
£10m - £15m
Sorry, no results match your filtered criteria.
The information has been supplied by each fund manager or company. British Patient Capital makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any such data or information. The information is for information only.
In cases where fund managers have different strategies for different funds, the information refers to the funds to which British Patient Capital has made commitments.
The investment range for funds typically refers to the amount at first investment, not the full amount that may be invested through further funding rounds, or by other investors that may join in a funding round.
For full information see the website terms and conditions.
Latest news & insights
British Patient Capital Invests £5.5m in Pragmatic Semiconductor
Read more Read more about British Patient Capital Invests £5.5m in Pragmatic Semiconductor
British Patient Capital announces £25m commitment to Oxx II
Read more Read more about British Patient Capital announces £25m commitment to Oxx II
